130 related articles for article (PubMed ID: 35259457)
1. A feedforward circuit between KLF5 and lncRNA KPRT4 contributes to basal-like breast cancer.
Du G; Sun J; Li Z; Zhang Q; Liu W; Yang C; Zhao P; Wang X; Yin Q; Luo Y; Song J; Wen Y; Wang H; Chen CH; Hu G; Zhou Z; Mao X; Liu W; Liu Z; Jiang D; Chen C
Cancer Lett; 2022 May; 534():215618. PubMed ID: 35259457
[TBL] [Abstract][Full Text] [Related]
2. YB-1 is a positive regulator of KLF5 transcription factor in basal-like breast cancer.
Jiang D; Qiu T; Peng J; Li S; Tala ; Ren W; Yang C; Wen Y; Chen CH; Sun J; Wu Y; Liu R; Zhou J; Wu K; Liu W; Mao X; Zhou Z; Chen C
Cell Death Differ; 2022 Jun; 29(6):1283-1295. PubMed ID: 35022570
[TBL] [Abstract][Full Text] [Related]
3. KLF5-induced lncRNA IGFL2-AS1 promotes basal-like breast cancer cell growth and survival by upregulating the expression of IGFL1.
Wang H; Shi Y; Chen CH; Wen Y; Zhou Z; Yang C; Sun J; Du G; Wu J; Mao X; Liu R; Chen C
Cancer Lett; 2021 Sep; 515():49-62. PubMed ID: 34052325
[TBL] [Abstract][Full Text] [Related]
4. KLF5 regulated lncRNA RP1 promotes the growth and metastasis of breast cancer via repressing p27kip1 translation.
Jia X; Shi L; Wang X; Luo L; Ling L; Yin J; Song Y; Zhang Z; Qiu N; Liu H; Deng M; He Z; Li H; Zheng G
Cell Death Dis; 2019 May; 10(5):373. PubMed ID: 31073122
[TBL] [Abstract][Full Text] [Related]
5. Targeting the KLF5-EphA2 axis can restrain cancer stemness and overcome chemoresistance in basal-like breast cancer.
Zhao P; Sun J; Huang X; Zhang X; Liu X; Liu R; Du G; Gan W; Yang C; Tang Y; Chen C; Jiang D
Int J Biol Sci; 2023; 19(6):1861-1874. PubMed ID: 37063424
[TBL] [Abstract][Full Text] [Related]
6. Inhibition of super enhancer downregulates the expression of KLF5 in basal-like breast cancers.
Chen CH; Yang N; Zhang Y; Ding J; Zhang W; Liu R; Liu W; Chen C
Int J Biol Sci; 2019; 15(8):1733-1742. PubMed ID: 31360115
[TBL] [Abstract][Full Text] [Related]
7. Arginine methyltransferase PRMT5 methylates and stabilizes KLF5 via decreasing its phosphorylation and ubiquitination to promote basal-like breast cancer.
Wang X; Qiu T; Wu Y; Yang C; Li Y; Du G; He Y; Liu W; Liu R; Chen CH; Shi Y; Pan J; Zhou J; Jiang D; Chen C
Cell Death Differ; 2021 Oct; 28(10):2931-2945. PubMed ID: 33972717
[TBL] [Abstract][Full Text] [Related]
8. LncRNA cancer susceptibility candidate 15 accelerates the breast cancer cells progression via miR-153-3p/KLF5 positive feedback loop.
Yu L; Xu Q; Yu W; Duan J; Dai G
Biochem Biophys Res Commun; 2018 Dec; 506(4):819-825. PubMed ID: 30389133
[TBL] [Abstract][Full Text] [Related]
9. Histone Deacetylase Inhibitors (HDACi) Promote KLF5 Ubiquitination and Degradation in Basal-like Breast Cancer.
Kong Y; Ren W; Fang H; Shah NA; Shi Y; You D; Zhou C; Jiang D; Yang C; Liang H; Liu W; Wang L; Gan W; Wan X; Li F; Li Z; Chen C; Xie N
Int J Biol Sci; 2022; 18(5):2104-2115. PubMed ID: 35342356
[TBL] [Abstract][Full Text] [Related]
10. Krüppel-like factor 5 promotes breast cell proliferation partially through upregulating the transcription of fibroblast growth factor binding protein 1.
Zheng HQ; Zhou Z; Huang J; Chaudhury L; Dong JT; Chen C
Oncogene; 2009 Oct; 28(42):3702-13. PubMed ID: 19668233
[TBL] [Abstract][Full Text] [Related]
11. DANCR Induces Cisplatin Resistance of Triple-Negative Breast Cancer by KLF5/p27 Signaling.
Su A; Yao K; Zhang H; Wang Y; Zhang H; Tang J
Am J Pathol; 2023 Mar; 193(3):248-258. PubMed ID: 36509121
[TBL] [Abstract][Full Text] [Related]
12. Kruppel-like factor 5 transcription factor promotes microsomal prostaglandin E2 synthase 1 gene transcription in breast cancer.
Xia H; Wang C; Chen W; Zhang H; Chaudhury L; Zhou Z; Liu R; Chen C
J Biol Chem; 2013 Sep; 288(37):26731-40. PubMed ID: 23913682
[TBL] [Abstract][Full Text] [Related]
13. The induction of KLF5 transcription factor by progesterone contributes to progesterone-induced breast cancer cell proliferation and dedifferentiation.
Liu R; Zhou Z; Zhao D; Chen C
Mol Endocrinol; 2011 Jul; 25(7):1137-44. PubMed ID: 21566082
[TBL] [Abstract][Full Text] [Related]
14. Long intergenic noncoding RNA 00908 promotes proliferation and inhibits apoptosis of colorectal cancer cells by regulating KLF5 expression.
Shan TD; Tian ZB; Li Q; Jiang YP; Liu FG; Sun XG; Han Y; Sun LJ; Chen L
J Cell Physiol; 2021 Feb; 236(2):889-899. PubMed ID: 33020901
[TBL] [Abstract][Full Text] [Related]
15. BAP1 promotes breast cancer cell proliferation and metastasis by deubiquitinating KLF5.
Qin J; Zhou Z; Chen W; Wang C; Zhang H; Ge G; Shao M; You D; Fan Z; Xia H; Liu R; Chen C
Nat Commun; 2015 Sep; 6():8471. PubMed ID: 26419610
[TBL] [Abstract][Full Text] [Related]
16. LncRNA BLAT1 is Upregulated in Basal-like Breast Cancer through Epigenetic Modifications.
Han YJ; Boatman SM; Zhang J; Du XC; Yeh AC; Zheng Y; Mueller J; Olopade OI
Sci Rep; 2018 Oct; 8(1):15572. PubMed ID: 30349062
[TBL] [Abstract][Full Text] [Related]
17. KLF5 promotes breast cancer proliferation, migration and invasion in part by upregulating the transcription of TNFAIP2.
Jia L; Zhou Z; Liang H; Wu J; Shi P; Li F; Wang Z; Wang C; Chen W; Zhang H; Wang Y; Liu R; Feng J; Chen C
Oncogene; 2016 Apr; 35(16):2040-51. PubMed ID: 26189798
[TBL] [Abstract][Full Text] [Related]
18. The interplay between TEAD4 and KLF5 promotes breast cancer partially through inhibiting the transcription of p27Kip1.
Wang C; Nie Z; Zhou Z; Zhang H; Liu R; Wu J; Qin J; Ma Y; Chen L; Li S; Chen W; Li F; Shi P; Wu Y; Shen J; Chen C
Oncotarget; 2015 Jul; 6(19):17685-97. PubMed ID: 25970772
[TBL] [Abstract][Full Text] [Related]
19. Ataxin-3 like (ATXN3L), a member of the Josephin family of deubiquitinating enzymes, promotes breast cancer proliferation by deubiquitinating Krüppel-like factor 5 (KLF5).
Ge F; Chen W; Qin J; Zhou Z; Liu R; Liu L; Tan J; Zou T; Li H; Ren G; Chen C
Oncotarget; 2015 Aug; 6(25):21369-78. PubMed ID: 26079537
[TBL] [Abstract][Full Text] [Related]
20. A stem cell marker KLF5 regulates CCAT1 via three-dimensional genome structure in colorectal cancer cells.
Takeda T; Yokoyama Y; Takahashi H; Okuzaki D; Asai K; Itakura H; Miyoshi N; Kobayashi S; Uemura M; Fujita T; Ueno H; Mori M; Doki Y; Fujii H; Eguchi H; Yamamoto H
Br J Cancer; 2022 Jan; 126(1):109-119. PubMed ID: 34707247
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
